Trust Company of Toledo’s Teva Pharmaceuticals TEVA Stock Holding History

Trust Company of Toledo’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.3K	Hold	600	–	–	﹤0.01%	607
2026 Q1	$18.1K	Hold	600	–	–	﹤0.01%	581
2025 Q4	$18.7K	Hold	600	–	–	﹤0.01%	553
2025 Q3	$12.1K	Hold	600	–	–	﹤0.01%	601
2025 Q2	$10.1K	Buy	+600	New	+$9.68K	﹤0.01%	613
2016 Q1	–	Sell	-3,073	Closed	-$202K	–	170
2015 Q4	$202K	Buy	+3,073	New	+$190K	0.06%	165
2015 Q2	–	Sell	-3,323	Closed	-$207K	–	184
2015 Q1	$207K	Buy	+3,323	New	+$193K	0.06%	174
2013 Q4	–	Sell	-8,361	Closed	-$316K	–	190
2013 Q3	$316K	Sell	8,361 -3,309	-28%	-$129K	0.11%	146
2013 Q2	$458K	Buy	+11,670	New	+$454K	0.17%	125

Other funds holding TEVA

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

YDMI

Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

AIIMS

Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

Trust Company of Toledo's TEVA Position: Q2 2026 in Review

Trust Company of Toledo held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 600 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #607.

Trust Company of Toledo first reported a position in TEVA in Q2 2013 and has held it in 9 quarters since. The position peaked at $458K in Q2 2013. 288 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Trust Company of Toledo held 600 shares of Teva Pharmaceuticals worth $20.3K as of Q2 2026.
Trust Company of Toledo left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #607 holding.
Trust Company of Toledo first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
Trust Company of Toledo's Teva Pharmaceuticals position peaked at $458K in Q2 2013.
288 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.